Structural basis for stem cell factor-KIT signaling and activation of class III receptor tyrosine kinases

Heli Liu1, Xiaoyan Chen, Pamela J Focia

  • 1Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

The EMBO Journal
|January 27, 2007
PubMed

Insights

Stem cell factor (SCF) binds to the KIT receptor, a receptor tyrosine kinase (RTK), initiating cellular processes. This study reveals the unique structural mechanism of SCF-KIT interaction, crucial for understanding RTK activation and related cancers.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biology

Background:

  • Stem cell factor (SCF) is a cytokine that activates the KIT receptor, a class III receptor tyrosine kinase (RTK).
  • KIT receptor dysregulation is implicated in various cancers, highlighting the importance of understanding its activation mechanism.
  • SCF binding to KIT regulates critical cellular functions like melanogenesis, gametogenesis, and hematopoiesis.

Purpose of the Study:

  • To elucidate the structural basis of Stem cell factor (SCF) binding to the extracellular ligand-binding domains of the KIT receptor.
  • To provide a molecular framework for understanding the activation mechanisms of class III receptor tyrosine kinases.

Main Methods:

  • X-ray crystallography was employed to determine the 2.5 Å crystal structure of the SCF/KIT complex.
  • Structural analysis focused on the interaction interface, receptor conformation, and cytokine recognition.

Main Results:

  • A novel 'wrapping' recognition mode was observed, where KIT adopts a bent conformation to interact with SCF via its first three immunoglobulin (Ig)-like domains.
  • Three distinct surface epitopes on SCF (extended loop, B and C helices, N-terminal segment) engage with different KIT domains.
  • Two SCF epitopes undergo significant conformational changes upon binding to KIT, revealing dynamic interactions.

Conclusions:

  • The SCF/KIT complex structure reveals a unique assembly for RTK dimerization and a novel interaction between four-helix bundle cytokines and Ig-family receptors.
  • This structural insight provides a foundation for understanding class III RTK activation and offers potential targets for therapeutic interventions in cancers associated with KIT dysregulation.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...